We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals

News   Jun 11, 2012

 
Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals
 
 
 

RELATED ARTICLES

Gender Differences in Self-Promotion of Research

News

In a recent study by Lerchenmueller et al., male scientists were found to frame their research findings more positively than female scientists and subsequently received higher rates of citations.

READ MORE

Targeting a Protease To Treat Inflammatory Bowel Disease

News

The protease MT1-MMP could be a possible future target for drugs to treat inflammatory bowel disease (IBD) according to a new study.

READ MORE

Ribosome-based Treatments: A Sought After Therapy Option for Orphan Diseases?

News

Recently, Urania Therapeutics announced that it has successfully raised €3.53M ($3.89M) in seed funding to unlock the therapeutic potential of ribosome-based treatments. We spoke with Jean-Paul Renaud, President and CSO of Urania Therapeutics, to learn more about the mechanisms of readthrough compounds and how the company hopes to provide treatment solutions for orphan diseases.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE